You just read:

Valeant Pharmaceuticals Increases Proposed Price for Acquisition of ISTA Pharmaceuticals Inc. to $7.50 Per Share in Cash

News provided by

Valeant Pharmaceuticals International, Inc.

Jan 17, 2012, 08:01 ET